• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国一个社区原发性胆汁性肝硬化的流行病学与自然史

Epidemiology and natural history of primary biliary cirrhosis in a US community.

作者信息

Kim W R, Lindor K D, Locke G R, Therneau T M, Homburger H A, Batts K P, Yawn B P, Petz J L, Melton L J, Dickson E R

机构信息

Division of Gastroenterology and Hepatology, Mayo Clinic and Foundation, Rochester, Minnesota 55905, USA.

出版信息

Gastroenterology. 2000 Dec;119(6):1631-6. doi: 10.1053/gast.2000.20197.

DOI:10.1053/gast.2000.20197
PMID:11113084
Abstract

BACKGROUND & AIMS: The epidemiology of primary biliary cirrhosis (PBC) has not been studied systematically in the United States. We report the incidence and prevalence of this condition in the general population. We also examined the validity of the Mayo natural history model for PBC among these unselected patients from the community.

METHODS

The Rochester Epidemiology Project entails a computerized index of diagnoses from the health care encounters of residents of Olmsted County, Minnesota. For potential cases identified using this database, the complete (inpatient and outpatient) medical records were reviewed to verify the diagnosis and extract information necessary for the application of the Mayo model. We estimated the incidence and prevalence of PBC in this population and compared the actual survival of patients with PBC in the community with the survival predicted for PBC patients by the Mayo natural history model.

RESULTS

The age-adjusted (to 1990 U.S. whites) incidence of PBC per 100,000 person-years for years 1975-1995 was 4.5 (95% confidence interval [CI], 3.1-5.9) for women, 0.7 (95% CI, 0.1-1.3) for men, and 2.7 (95% CI, 1.9-3.5) overall. The age- and sex-adjusted prevalence per 100,000 persons as of 1995 was 65.4 (95% CI, 43.0-87.9) for women, 12.1 (95% CI, 1.1-23.1) for men, and 40.2 (95% CI, 27.2-53.1) overall. The Mayo natural history model accurately predicted the actual survival of these patients.

CONCLUSIONS

This first description of the epidemiology of PBC in the United States indicates that its incidence and prevalence in this country are among the highest reported. Outcomes among these unselected patients from a community population further validated the Mayo natural history model of PBC.

摘要

背景与目的

原发性胆汁性肝硬化(PBC)的流行病学在美国尚未得到系统研究。我们报告了这种疾病在普通人群中的发病率和患病率。我们还在这些来自社区的未经选择的患者中检验了梅奥PBC自然史模型的有效性。

方法

罗切斯特流行病学项目包含明尼苏达州奥尔姆斯特德县居民医疗保健接触的计算机化诊断索引。对于使用该数据库识别出的潜在病例,查阅完整的(住院和门诊)病历以核实诊断并提取应用梅奥模型所需的信息。我们估计了该人群中PBC的发病率和患病率,并将社区中PBC患者的实际生存率与梅奥自然史模型预测的PBC患者生存率进行了比较。

结果

1975 - 1995年期间,年龄调整后(以1990年美国白人标准)每10万人年的PBC发病率,女性为4.5(95%置信区间[CI],3.1 - 5.9),男性为0.7(95% CI,0.1 - 1.3),总体为2.7(95% CI,1.9 - 3.5)。截至1995年,年龄和性别调整后的每10万人患病率,女性为65.4(95% CI,43.0 - 87.9),男性为12.1(95% CI,1.1 - 23.1),总体为40.2(95% CI,27.2 - 53.1)。梅奥自然史模型准确预测了这些患者的实际生存率。

结论

美国对PBC流行病学的首次描述表明,该国PBC的发病率和患病率在已报告的情况中处于最高水平。这些来自社区人群的未经选择的患者的结局进一步验证了PBC的梅奥自然史模型。

相似文献

1
Epidemiology and natural history of primary biliary cirrhosis in a US community.美国一个社区原发性胆汁性肝硬化的流行病学与自然史
Gastroenterology. 2000 Dec;119(6):1631-6. doi: 10.1053/gast.2000.20197.
2
Epidemiology and natural history of primary biliary cirrhosis in a Canadian health region: a population-based study.加拿大某健康地区原发性胆汁性肝硬化的流行病学及自然史:一项基于人群的研究。
Hepatology. 2009 Dec;50(6):1884-92. doi: 10.1002/hep.23210.
3
Increasing Prevalence of Primary Biliary Cholangitis and Reduced Mortality With Treatment.原发性胆汁性胆管炎的发病率上升和治疗后死亡率降低。
Clin Gastroenterol Hepatol. 2018 Aug;16(8):1342-1350.e1. doi: 10.1016/j.cgh.2017.12.033. Epub 2017 Dec 23.
4
Rising incidence and prevalence of primary biliary cirrhosis: a large population-based study.原发性胆汁性肝硬化发病率和患病率的上升:一项基于大规模人群的研究。
Liver Int. 2014 Jul;34(6):e31-8. doi: 10.1111/liv.12434. Epub 2014 Jan 14.
5
Low incidence of primary biliary cirrhosis (PBC) in the first-degree relatives of PBC probands after 8 years of follow-up.对原发性胆汁性肝硬化(PBC)先证者的一级亲属进行8年随访后发现,其原发性胆汁性肝硬化发病率较低。
Liver Int. 2016 Sep;36(9):1378-82. doi: 10.1111/liv.13143. Epub 2016 Apr 28.
6
Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community.美国一个社区中原发性硬化性胆管炎的发病率、临床谱及预后
Gastroenterology. 2003 Nov;125(5):1364-9. doi: 10.1016/j.gastro.2003.07.011.
7
The epidemiology and natural history of primary biliary cirrhosis: a nationwide population-based study.原发性胆汁性肝硬化的流行病学和自然史:一项全国范围内基于人群的研究。
Eur J Gastroenterol Hepatol. 2012 Jul;24(7):824-30. doi: 10.1097/MEG.0b013e328353753d.
8
Population-based epidemiology of primary biliary cirrhosis in South Korea.韩国原发性胆汁性肝硬化的基于人群的流行病学研究。
Aliment Pharmacol Ther. 2016 Jan;43(1):154-62. doi: 10.1111/apt.13448. Epub 2015 Nov 2.
9
Incidence and Prevalence of Crohn's Disease and Ulcerative Colitis in Olmsted County, Minnesota From 1970 Through 2010.1970年至2010年明尼苏达州奥尔姆斯特德县克罗恩病和溃疡性结肠炎的发病率及患病率
Clin Gastroenterol Hepatol. 2017 Jun;15(6):857-863. doi: 10.1016/j.cgh.2016.10.039. Epub 2016 Nov 14.
10
Prevalence and incidence of primary biliary cirrhosis are increasing in Finland.芬兰原发性胆汁性肝硬化的患病率和发病率正在上升。
Scand J Gastroenterol. 2007 Nov;42(11):1347-53. doi: 10.1080/00365520701396034.

引用本文的文献

1
A nationwide study of primary biliary cholangitis prevalence, geographic distribution, and health care providers.一项关于原发性胆汁性胆管炎患病率、地理分布及医疗服务提供者的全国性研究。
Hepatol Commun. 2025 Apr 14;9(5). doi: 10.1097/HC9.0000000000000677. eCollection 2025 May 1.
2
Integrating Molecular Testing With Clinical Criteria and Histopathology Improves Diagnostic Precision in Immune-Mediated Liver Diseases.将分子检测与临床标准及组织病理学相结合可提高免疫介导性肝病的诊断准确性。
Mod Pathol. 2025 May;38(5):100728. doi: 10.1016/j.modpat.2025.100728. Epub 2025 Feb 4.
3
Up-to-Date Snapshot of Current and Emerging Medical Therapies in Primary Biliary Cholangitis.
原发性胆汁性胆管炎当前及新兴医学疗法的最新概况
J Pers Med. 2024 Nov 30;14(12):1133. doi: 10.3390/jpm14121133.
4
Cross-Phenotype Genome-Wide Association Study on the Shared Genetic Susceptibility to Systemic Sclerosis and Primary Biliary Cholangitis.系统性硬化症和原发性胆汁性胆管炎共同遗传易感性的跨表型全基因组关联研究
Arthritis Rheumatol. 2025 Jun;77(6):727-739. doi: 10.1002/art.43081. Epub 2025 Feb 27.
5
Factors associated with progression and outcomes of primary biliary cholangitis: A cohort study, 2010-2019.原发性胆汁性胆管炎进展及预后的相关因素:一项2010 - 2019年的队列研究
J Res Med Sci. 2024 Sep 30;29:59. doi: 10.4103/jrms.jrms_813_22. eCollection 2024.
6
Review of Current and Upcoming Second-Line Treatments for Primary Biliary Cholangitis.原发性胆汁性胆管炎当前及即将出现的二线治疗方法综述
Dig Dis Sci. 2025 Jan;70(1):100-110. doi: 10.1007/s10620-024-08742-w. Epub 2024 Dec 2.
7
COBALT: A Confirmatory Trial of Obeticholic Acid in Primary Biliary Cholangitis With Placebo and External Controls.钴:一项使用安慰剂和外部对照的奥贝胆酸治疗原发性胆汁性胆管炎的验证性试验。
Am J Gastroenterol. 2025 Feb 1;120(2):390-400. doi: 10.14309/ajg.0000000000003029. Epub 2024 Aug 14.
8
A Review on Biomarkers for the Evaluation of Autoimmune Cholestatic Liver Diseases and Their Overlap Syndromes.自身免疫性胆汁淤积性肝病及其重叠综合征评估的生物标志物综述
Front Mol Med. 2022 Jul 8;2:914505. doi: 10.3389/fmmed.2022.914505. eCollection 2022.
9
Cross-Phenotype GWAS Supports Shared Genetic Susceptibility to Systemic Sclerosis and Primary Biliary Cholangitis.跨表型全基因组关联研究支持系统性硬化症和原发性胆汁性胆管炎存在共同遗传易感性。
medRxiv. 2024 Jul 3:2024.07.01.24309721. doi: 10.1101/2024.07.01.24309721.
10
Acquired ductopenia: an insight into imaging findings.获得性胆管减少症:影像学表现的深入探讨
Abdom Radiol (NY). 2025 Jan;50(1):152-168. doi: 10.1007/s00261-024-04462-x. Epub 2024 Jul 2.